U.S. Cardiovascular Health Supplements Market (2025 - 2030) Size, Share & Trends Analysis Report By Ingredient (Vitamins & Minerals, Herbs & Botanicals, Omega Fatty Acids), By Form (Liquid, Tablet), By, Type, By Distribution Channel, By Region, And Segment Forecasts

Market Size & Trends

The U.S. cardiovascular health supplements market size was estimated at 2.11 billion in 2024 and is projected to grow at a CAGR of 7.61% from 2025 to 2030. This growth is driven by rising awareness of heart health, increasing prevalence of cardiovascular diseases, and a growing aging population seeking preventive healthcare. Consumer preference is shifting toward natural and functional supplements, while advancements in nutraceutical formulations are enhancing product efficacy. In addition, supportive regulatory frameworks and increased availability across online and retail channels are further fueling market expansion.

Impact of Aging Population on Cardiovascular Supplement Demand

The aging population in the U.S. is a significant driver of growth in the cardiovascular health supplements industry. As an individual ages, the risk of developing cardiovascular diseases such as coronary artery disease, hypertension, and heart failure increases sharply. According to the U.S. Census Bureau, adults 65 and older will comprise over 20% of the population by 2030, significantly expanding the target consumer base for heart health supplements. This demographic shift is prompting a surge in demand for preventive healthcare solutions, particularly natural and evidence-based nutraceuticals. Older adults are more likely to prioritize heart health and are increasingly seeking convenient, non-prescription methods to manage chronic conditions, prevent disease progression, and improve quality of life.

Manufacturers are responding to this growing demand by developing specialized cardiovascular supplements tailored for older consumers. These products often include omega-3 fatty acids, CoQ10, magnesium, and plant sterol ingredients known for their heart-protective properties. Moreover, innovations in supplement delivery formats such as softgels, extended-release capsules, and combination formulas are designed to improve compliance among the elderly. In addition, the growing influence of caregivers, healthcare providers, and online health platforms is pivotal in guiding seniors toward proactive supplement use. As this population segment continues to expand, its emphasis on longevity and preventive care is expected to remain a central force in shaping the future growth trajectory of the U.S. cardiovascular health supplements industry.

Rising Cardiovascular Disease Burden Drives Supplement Uptake

The rising burden of cardiovascular-related diseases (CVDs) in the U.S. has become a major public health concern and a significant driver for the growth of the cardiovascular health supplements industry. Sedentary lifestyles, unhealthy diets, stress, and aging are key contributors to the increasing incidence of conditions such as heart attacks, high blood pressure, and stroke. As a result, there is heightened consumer awareness around preventive health, leading to increased adoption of dietary supplements that support cardiovascular function.

Cardiovascular-related deaths in the U.S. are significantly influenced by a range of conditions, with coronary heart disease accounting for the most significant proportion at 40.3%. This is followed by stroke (17.5%) and other minor cardiovascular disease (CVD) causes, collectively contributing 17.1%. High blood pressure (13.4%), heart failure (9.1%), and diseases of the arteries (2.6%) also represent critical contributors. These figures highlight the urgent need for preventive interventions such as targeted cardiovascular health supplements to address the spectrum of CVD risks.

In response, the market has seen increased innovation and diversification in product formulations, with ingredients such as omega-3 fatty acids, CoQ10, magnesium, and plant sterols gaining traction. The growing demand from both aging consumers and younger individuals focused on preventive care reflects a long-term shift toward holistic wellness. As cardiovascular diseases continue to dominate national health statistics, the role of supplements as supportive, non-prescription interventions is expected to strengthen further.

Market Concentration & Characteristics

Innovation in the U.S. cardiovascular health supplements industry is accelerating, driven by advancements in nutraceutical science, personalized nutrition, and novel delivery formats. Companies are leveraging technology to enhance bioavailability, improve consumer compliance, and develop targeted formulations for specific heart health concerns.

The U.S. cardiovascular health supplements industry features moderate collaboration with partnerships primarily focused on research, product development, and clinical validation. While major players engage in selective alliances with biotech firms and academic institutions, broader industry consolidation remains limited, allowing for competitive differentiation and innovation-driven growth.

Regulatory frameworks, primarily governed by the FDA, significantly impact the U.S. cardiovascular health supplements industry. Compliance with guidelines ensures product safety, accurate labeling, and consumer trust. Stricter regulations drive companies to invest in quality control, clinical substantiation, and transparent practices to meet industry standards.

The U.S. cardiovascular health supplements industry is seeing rapid growth and product expansion, driven by rising consumer awareness of heart health and increasing demand for preventive solutions. Companies are diversifying their portfolios with innovative formulations, including plant-based ingredients and functional blends, while focusing on improving bioavailability and product efficacy. Wider distribution channels and evolving consumer preferences for natural, science-backed supplements further support this expansion.

Ingredient Insights

Based on ingredient, the market is segmented into vitamins & minerals, herbs & botanicals, omega fatty acids, coenzyme Q10 (CoQ10), and others. The omega fatty acids held the largest revenue share of 27.36% in 2024, driven by their well-established benefits for heart health, including reducing cholesterol levels and inflammation. The growing consumer preference for natural, scientifically supported supplements and increased awareness of omega-3s’ cardiovascular benefits further fueled demand. In addition, their wide availability in various supplement forms contributed to their dominant market position.

Herbs & botanicals are expected to grow at the fastest CAGR due to rising consumer demand for natural, plant-based supplements. The increasing popularity of holistic health practices and the cardiovascular benefits of herbs like garlic and turmeric drive this growth and shift toward sustainable, clean-label products.

Type Insights

Natural supplements held the largest revenue share in 2024 and are anticipated to grow at the fastest CAGR over the forecast period. This was driven by a shift in consumer preference toward clean, plant-based products perceived as safer and more effective. Growing awareness of the cardiovascular benefits of natural ingredients, such as omega-3s, herbal extracts, and antioxidants, further fueled this trend. In addition, the increasing demand for sustainable, environmentally friendly products and the rise of holistic wellness practices drove market growth in the natural supplements segment.

The synthetic supplements segment is expected to register significant CAGR over the forecast period, driven by advancements in formulation technology, cost-effectiveness, and growing consumer demand for targeted, scientifically backed solutions. In addition, increasing adoption by fitness enthusiasts and athletes further propels the growth of synthetic supplements. Thereby propelling the growing demand for the segment over the forecast period.

Form Insights

Based on form, the market is segmented into liquid, tablet, capsules, softgels, powder, and others. The softgels held the largest revenue share of 36.91% in 2024, driven by their convenience, ease of consumption, and enhanced bioavailability. Consumers prefer softgels for their precise dosage, quicker absorption, and ability to encapsulate various ingredients, including omega-3s and herbal extracts. In addition, their popularity among elderly and health-conscious consumers further increased market dominance.

Capsules are expected to grow at the fastest CAGR due to their convenience, precise dosage, and versatility in delivering active ingredients. The increasing consumer preference for easy-to-swallow formats and the growing demand for personalized health solutions further contribute to the rapid growth of capsules in the market.

Distribution Channel Insights

The offline segment held the largest market share in 2024. This is due to strong consumer trust in in-store purchases, personalized consultations, and immediate product availability. Pharmacies, health stores, and supermarkets remain key distribution channels, especially for older consumers who prefer physical retail experiences. Promotional displays and in-store recommendations also played a significant role in driving offline sales of cardiovascular health supplements.

As a distribution channel, online is expected to witness the fastest CAGR over the forecast period due to increasing internet penetration, convenience of home delivery, and growing consumer preference for digital shopping. Enhanced product visibility, access to a wider range of brands, and personalized recommendations also contribute to the rapid growth of e-commerce in the supplements market.

Key U.S. Cardiovascular Health Supplements Company Insights

A competitive mix of established leaders and emerging players characterizes the U.S. cardiovascular health supplements industry. Companies such as NOW Foods, Nordic Naturals, Thorne, and GNC Holdings, LLC dominate the space with extensive product portfolios, substantial brand equity, and clinically supported formulations. Nestlé Health Science (Pure Encapsulations, LLC) and Amway Corp. leverage global scale and R&D investments to offer premium, science-backed supplements tailored for heart health, securing a significant share in retail and practitioner-recommended segments.

Emerging brands such as Bright Lifecare Private Ltd (Truebasics.com) and InVite Health are expanding rapidly, driven by digital-first strategies and growing demand for personalized, natural supplements. DaVinci Laboratories of Vermont and Natural Organics, Inc. continue to build credibility in niche, professional-grade markets. As consumer preferences shift toward clean-label, transparent, and evidence-based products, innovation, quality assurance, and omnichannel presence remain key competitive differentiators across the market.

Numerous participants operate in the market. Firms in the industry are undertaking numerous strategies, such as launching novel products, partnerships, and collaborations, to maintain their market presence.

Recent Developments

• In May 2025, NOW launched its “Be You, NOW” campaign during Women’s Health Month, featuring insights from female wellness experts to support women of all ages in maintaining their fitness and well-being routines.

• In April 2025, Zydus Lifesciences secures FDA approval for its Niacin ER (Extended Release) tablets, marking a significant step in expanding its cardiovascular therapeutic portfolio in the U.S. market.

U.S. Cardiovascular Health Supplements Market Report Scope

U.S. Cardiovascular Health Supplements Market Report Segmentation

This report forecasts revenue growth and analyzes the latest trends in each of the sub-segments from 2018 to 2030. Grand View Research has segmented the U.S. cardiovascular health supplements market report based on ingredient, type, form, and distribution channel:

• Ingredient Outlook (Revenue, USD Million, 2018 - 2030)

  • Vitamins & Minerals

  • Herbs & Botanicals

  • Omega Fatty Acids

  • Coenzyme Q10 (CoQ10)

  • Others

• Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Natural Supplements

  • Synthetic Supplements

• Form Outlook (Revenue, USD Million, 2018 - 2030)

  • Liquid

  • Tablet

  • Capsules

  • Softgels

  • Powder

  • Others

• Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

  • Offline

  • Online